2020 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2020: 67 approvals, 0 patent expiries, 0 Phase 3 milestones.

20182019202020212022

FDA / EMA / MHRA approvals (67)

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.